Skip to content

Dare Bioscience, Inc.

DARE

CIK 0001401914

← back to feed
Revenue (TTM)
$221.84K
+10,429.4% YoY Q1 May 2026
Net Income (TTM)
−$14.96M
−230.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.44
−150.0% YoY Q1 May 2026
Gross Margin
-33.3%
Q1 May 2026
Operating Margin
-6,797.8%
Q1 May 2026
Net Margin
-6,742.6%
Q1 May 2026
Free Cash Flow (TTM)
−$34.09M
Q1 May 2026
Cash
$18.52M
Q1 May 2026
Total Debt
$10.54K
Q1 May 2026
Shares Outstanding
14.98M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings